Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiya Tanaka

Showing results (61-70 of 1,035) with videos related to

Pageof 104
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 1, 2009
Jak inhibitor ; possibility and mechanism as a new disease modifying anti-rheumatic drugKunihiro Yamaoka, Yoshiya Tanaka
Drugs|November 13, 2014
Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritisYoshiya Tanaka, Shintaro Hirata
International Journal of Rheumatic Diseases|April 25, 2025
Targeted Therapies for Rheumatoid Arthritis in Super-Elderly Society: Insights From FIRST Registry, JapanKoshiro Sonomoto, Yoshiya Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 22, 2013
[JAK inhibitor]Kunihiro Yamaoka, Yoshiya Tanaka
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) scoreShintaro Hirata, Yoshiya Tanaka
Immunological Medicine|October 5, 2020
Potential of B-cell-targeting therapy in overcoming multidrug resistance and tissue invasiveness associated with P-glycoprotein expressing-B cell compartmentsShizuyo Tsujimura, Yoshiya Tanaka
Expert Review of Clinical Immunology|September 1, 2021
Clinical relevance of T follicular helper cells in systemic lupus erythematosusShingo Nakayamada, Yoshiya Tanaka
Expert Review of Clinical Immunology|November 1, 2023
Bimekizumab for the treatment of psoriatic arthritisYoshiya Tanaka, Stevan Shaw
Expert Review of Clinical Immunology|August 14, 2023
Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlookKoshiro Sonomoto, Yoshiya Tanaka
Biomolecules|June 28, 2023
Immune Phenotype as a Biomarker for Systemic Lupus ErythematosusShingo Nakayamada, Yoshiya Tanaka
Pageof 104

Showing results (61-70 of 1,035) with videos related to

Sort By:
Pageof 104
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 1, 2009
Jak inhibitor ; possibility and mechanism as a new disease modifying anti-rheumatic drugKunihiro Yamaoka, Yoshiya Tanaka
Drugs|November 13, 2014
Intensive intervention can lead to a treatment holiday from biological DMARDs in patients with rheumatoid arthritisYoshiya Tanaka, Shintaro Hirata
International Journal of Rheumatic Diseases|April 25, 2025
Targeted Therapies for Rheumatoid Arthritis in Super-Elderly Society: Insights From FIRST Registry, JapanKoshiro Sonomoto, Yoshiya Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 22, 2013
[JAK inhibitor]Kunihiro Yamaoka, Yoshiya Tanaka
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 17, 2016
Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) scoreShintaro Hirata, Yoshiya Tanaka
Immunological Medicine|October 5, 2020
Potential of B-cell-targeting therapy in overcoming multidrug resistance and tissue invasiveness associated with P-glycoprotein expressing-B cell compartmentsShizuyo Tsujimura, Yoshiya Tanaka
Expert Review of Clinical Immunology|September 1, 2021
Clinical relevance of T follicular helper cells in systemic lupus erythematosusShingo Nakayamada, Yoshiya Tanaka
Expert Review of Clinical Immunology|November 1, 2023
Bimekizumab for the treatment of psoriatic arthritisYoshiya Tanaka, Stevan Shaw
Expert Review of Clinical Immunology|August 14, 2023
Malignancies and rheumatoid arthritis, csDMARDs, biological DMARDs, and JAK inhibitors: challenge and outlookKoshiro Sonomoto, Yoshiya Tanaka
Biomolecules|June 28, 2023
Immune Phenotype as a Biomarker for Systemic Lupus ErythematosusShingo Nakayamada, Yoshiya Tanaka
Pageof 104